Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.46 - $5.2 $24,720 - $52,254
-10,049 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$7.65 - $11.38 $2.49 Million - $3.71 Million
-325,724 Reduced 97.01%
10,049 $85,000
Q3 2021

Nov 15, 2021

SELL
$9.93 - $13.59 $793,059 - $1.09 Million
-79,865 Reduced 19.22%
335,773 $3.9 Million
Q2 2021

Aug 16, 2021

BUY
$11.87 - $15.96 $1.25 Million - $1.69 Million
105,656 Added 34.08%
415,638 $5.22 Million
Q1 2021

May 17, 2021

SELL
$13.87 - $21.04 $659,962 - $1 Million
-47,582 Reduced 13.31%
309,982 $4.3 Million
Q4 2020

Feb 16, 2021

BUY
$17.03 - $22.45 $2.19 Million - $2.88 Million
128,345 Added 55.99%
357,564 $7.09 Million
Q3 2020

Nov 16, 2020

BUY
$19.3 - $26.92 $3.27 Million - $4.56 Million
169,219 Added 282.03%
229,219 $5.24 Million
Q2 2020

Aug 14, 2020

BUY
$22.0 - $22.5 $1.32 Million - $1.35 Million
60,000 New
60,000 $1.35 Million

About Akouos, Inc.


  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.